PURPOSE: To evaluate dose errors in balloon catheter brachytherapy of breast cancer due to inhomogeneities, such as iodine-containing radiographic contrast medium in the balloon, the lack of scattering medium, and the low density of lung that are not considered by commercial treatment planning systems (TPS). METHODS AND MATERIALS: By accounting for these inhomogeneities in breast/lung phantoms, Monte Carlo simulations were performed to calculate doses in the breast and lung. Doses were also calculated by a commercial TPS. The Monte Carlo doses and the TPS doses were compared along the transverse and longitudinal axes of the source. RESULTS: The Monte Carlo doses were lower by 4-10% on the prescription line than the TPS doses, depending on the concentration (5-25% by volume) of the contrast medium, and on the direction from the source. The lack of scattering medium around the breast contributes to the differences more than the attenuation by the contrast medium. Attenuation contributed approximately 1.0-4.8% at the concentrations investigated in this study. CONCLUSIONS: Current treatment planning systems, which assume a source in a large homogeneous water-equivalent medium, significantly overestimate doses in breast brachytherapy.
PURPOSE: To evaluate dose errors in balloon catheter brachytherapy of breast cancer due to inhomogeneities, such as iodine-containing radiographic contrast medium in the balloon, the lack of scattering medium, and the low density of lung that are not considered by commercial treatment planning systems (TPS). METHODS AND MATERIALS: By accounting for these inhomogeneities in breast/lung phantoms, Monte Carlo simulations were performed to calculate doses in the breast and lung. Doses were also calculated by a commercial TPS. The Monte Carlo doses and the TPS doses were compared along the transverse and longitudinal axes of the source. RESULTS: The Monte Carlo doses were lower by 4-10% on the prescription line than the TPS doses, depending on the concentration (5-25% by volume) of the contrast medium, and on the direction from the source. The lack of scattering medium around the breast contributes to the differences more than the attenuation by the contrast medium. Attenuation contributed approximately 1.0-4.8% at the concentrations investigated in this study. CONCLUSIONS: Current treatment planning systems, which assume a source in a large homogeneous water-equivalent medium, significantly overestimate doses in breast brachytherapy.
Authors: Wonmo Sung; Sung-Joon Ye; Aimee L McNamara; Stephen J McMahon; James Hainfeld; Jungwook Shin; Henry M Smilowitz; Harald Paganetti; Jan Schuemann Journal: Nanoscale Date: 2017-05-11 Impact factor: 7.790
Authors: David Aramburu Nunez; Michael Trager; Joel Beaudry; Gilad N Cohen; Lawrence T Dauer; Daniel Gorovets; Nima Hassan Rezaeian; Marisa A Kollmeier; Brian Leong; Patrick McCann; Matthew Williamson; Michael J Zelefsky; Antonio L Damato Journal: Brachytherapy Date: 2021-06-27 Impact factor: 2.441
Authors: Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert Journal: Radiother Oncol Date: 2013-11-30 Impact factor: 6.280
Authors: Chang Hyun Choi; Sung-Joon Ye; E Ishmael Parsai; Sui Shen; Ruby Meredith; Ivan A Brezovich; Roger Ove Journal: J Appl Clin Med Phys Date: 2009-02-03 Impact factor: 2.102